Phreesia (NYSE:PHR) vs. Hims & Hers Health (NYSE:HIMS) Financial Review

Phreesia (NYSE:PHR) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Phreesia and Hims & Hers Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$419.81 million	4.11	-$58.53 million	($0.74)	-39.18
Hims & Hers Health	$1.48 billion	7.26	$126.04 million	$0.69	69.44

Hims & Hers Health has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Phreesia has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500.

Profitability

This table compares Phreesia and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	-9.83%	-16.23%	-11.19%
Hims & Hers Health	9.24%	22.75%	15.51%

Insider and Institutional Ownership

92.1% of Phreesia shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.5% of Phreesia shares are held by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Phreesia and Hims & Hers Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	0	0	11	0	3.00
Hims & Hers Health	3	8	2	0	1.92

Phreesia currently has a consensus price target of $31.64, indicating a potential upside of 9.13%. Hims & Hers Health has a consensus price target of $39.58, indicating a potential downside of 17.39%. Given Phreesia’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Phreesia is more favorable than Hims & Hers Health.

Summary

Hims & Hers Health beats Phreesia on 10 of the 14 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.